Atripla (efavirenz recalls

The FDA has published 1 recall involving Atripla (efavirenz since 2014. The latest was reported on 5 Mar 2014. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 5 Mar 2014

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why atripla (efavirenz is recalled

Particulate Matter1100%

Companies

Gilead Sciences1100%

By year

20141100%

All atripla (efavirenz recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
5 Mar 2014Drug	CLASS III	Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir recalled	Gilead Sciences	Particulate Matter	Nationwide

Should you stop taking Atripla (efavirenz?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.